開啟主選單
求真百科
搜尋
檢視 杨吉春 的原始碼
←
杨吉春
由於下列原因,您沒有權限進行 編輯此頁面 的動作:
您請求的操作只有這個群組的使用者能使用:
用戶
您可以檢視並複製此頁面的原始碼。
{| class="wikitable" style="float:right; margin: -10px 0px 10px 20px; text-align:left" |<center>''' 杨吉春 '''<br><img src=" https://sbms.bjmu.edu.cn/images/2021-05/e62d02a74bb34684bc1747c3843683b0.jpg " width="180"></center><small>[https://sbms.bjmu.edu.cn/jsdw/bssds/39bcb753e70d47fa82d9d407aeb9c87b.htm 北京大学基础医学院]</small> |} '''杨吉春''',男,北京大学基础医学院教授。 ==人物履历== 1993.9-1997.7 北京大学生命科学学院 生化分子生物学专业 本科 1997.9-2002.7 北京大学生命科学学院 生化分子生物学专业 博士 2003.4-2006.5 美国宾夕法尼亚大学医学院 博士后 2006.6-2014.6 北京大学医学部基础医学院生理学与病理生理学系 副教授 2014.6-现今 北京大学医学部基础医学院生理学与病理生理学系 教授 ==研究领域== [[2型糖尿病]]及其[[血管病变]]发生机制;研究方向:胰岛β细胞功能障碍及肝脏糖脂代谢异常在2型糖尿病发生发展过程中的作用;糖尿病血管病变。 ==研究课题== 1)[[胰岛β细胞]]增殖及胰岛素分泌调控机制研究。FAM3新基因家族在胰岛素β细胞功能代谢调控中的作用。营养物质代谢对β细胞功能代谢的调控。 2)脂肪肝发生机制及其在血糖稳态失衡过程中的作用。 3)核受体PPARs在机体糖脂代谢及改善糖尿病并发症中的作用及机制。 4)非编码RNA(miRNAs/LncRNAs)在糖脂代谢调控中的作用。 ==获奖情况== 2013 国家优秀青年科学基金 2008 教育部新世纪优秀人才计划 2012 北京大学绿叶生物医药杰出青年学者奖 2012 北京大学医学部优秀人才计划 2011 中国生理学会第11届张锡钧优秀论文奖(二等奖) 2012 北京大学医学部优秀教师 2009 北京大学医学部优秀青年学者 2011 北京大学医学部基础医学院优秀SCI论文一等奖 2011 北京大学医学部基础医学院优秀SCI论文二等奖 2012 北京大学医学部基础医学院教学比赛二等奖 2012 北京大学青年教师教学比赛三等奖 2007 基础医学院青年教师教学比赛三等奖 2012 基础医学院优秀青年奖励基金获得者 2013 基础医学院优秀SCI论文奖 2014 基础医学院优秀SCI论文奖 2005 JDRF优秀博士后奖励基金(10万美元/2年) 所指导研究生获得荣誉: 北京市优秀毕业生 (王春炅2013) 北京大学优秀毕业生(李晶2011;王春炅2013;陈真真2014;陈霁2015 ) 中国病理生理学会第9届学术大会优秀青年论文2等奖(李晶2010) 中国生理学会第十届青年生理工作者学术会议优秀报告奖(陈真真2013) 中国生理学会张锡均优秀论文2等奖(王春炅2015) ==研究基金== 1. JDRF postdoctoral fellowship grant (Grant No: 3-2005-1048). 2005.8 – 2007.7月100,000美元 项目负责人 2. 国家自然科学基金面上项目:PANDER诱导肝细胞胰岛素抵抗的机制研究(30771030)2008.1- 20010.12 30 万 项目负责人 3. 教育部留学回国人员科研启动基金 2008 2 万 项目负责人 4. 国家自然科学基金面上项目:ATP合成酶在β细胞功能障碍中的作用研究(30870995) 2009.1 – 20011.12 33 万 项目负责人 5. 自然基金委重大项目“代谢性核受体在机体糖脂代谢调控中的作用” (30890041) 2009.1-2012.12 本人经费100 万 主要学术骨干 6. 973项目“畜禽肌肉和脂肪发育的分子调控机制研究” (2009CB941603) 2009.1-2013.12 本人经费50 万 主要学术骨干 7. 2008年度教育部新世纪优秀人才专项基金(NCET-08-0009) 2009-2011 50 万 项目负责人 8. 973项目“糖尿病发病机制的研究” 2006-2010 学术骨干(中期加入) 9. 国家自然科学基金面上项目:PANDER-FOXO1信号通路在非酒精性脂肪肝发生过程中的作用(81170791)2012-2015 70万项目负责人 10. 973项目“脂质代谢异常导致脂肪肝及高脂血症的分子机制研究”(2012CB517504) 2012.1-2016.12 本人经费70万 学术骨干 11. 国家重大新药计划“基于新靶点的抗脂肪肝小核酸药物的临床前研究”(2011ZX09102-011-12) 2012-2014 本人经费30万 学术骨干 12. 北京市自然科学基金面上项目:PANDER诱导肝脏脂质沉积的机制研究(7122107) 2012.1-2014.12 11万 项目负责人 13.国家优秀青年科学基金(81322011) 2014.1-2016.12 100万 项目负责人 14. 国家自然基金面上项目:FAM3A在胰岛素分泌调控中的作用及机制(81471035) 2015.1-2018.12 80万 项目负责人 ==学术兼职== 目前应邀为Diabetes、Journal of Diabetes、Journal of Endocrinology、Nutrition &Metabolism、PloS One、Int J Biochem Cell Biol、《中国药理学通报》、《中国科学C辑》、《生理科学进展》等10余家国内外学术期刊审稿。ISRN Nutrition及《中国糖尿病杂志》杂志编委。教育部《中国科技论文在线》特聘专家。教育部留学回国科研基金会评专家。国家自然基金委通讯评审专家。 ==学术成果== Publication list (* Corresponding author) 1.Wang J, Ma R, Ma W, Chen J, Yang J*, Xi Y*, Cui Q*. LncDisease: a sequence based bioinformatics tool for predicting lncRNA-disease associations. Nucleic Acids Res . 2016 Feb 16. pii: gkw093. [Epub ahead of print] 2.Cai J, Shi X, Wang H, Fan J, Feng Y, Lin X, Yang J, Cui Q, Tang C, Xu G, Geng B.Cystathionine γ lyase-hydrogen sulfide increases peroxisome proliferator-activated receptor γ activity by sulfhydration at C139 site thereby promoting glucose uptake and lipid storage in adipocytes. Biochim Biophys Acta . 2016 Mar 2. [Epub ahead of print] 3.Liao F, Zheng Y, Cai J, Fan J, Wang J, Yang J, Cui Q, Xu G, Tang C, Geng B. Catestatin attenuates endoplasmic reticulum induced cell apoptosis by activation type 2 muscarinic acetylcholine receptor in cardiac ischemia/reperfusion. Sci Rep . 2015 Nov 16;5:16590. doi: 10.1038/srep16590. 4.Chen Z, Luo Y, Yang W, Ding L, Wang J, Geng B, Cui Q* and Yang J*. Comparison analysis of dysregulated LncRNA profile in plasma and liver of mice after hepatic ischemia/reperfusion injury. PloS One 2015 Jul 29;10(7):e0133462. 5.Zhang X, Liu J, Yang J* and Guan Y*. FAM3A and FAM3B (PANDER) are a pair of Yin-Yang regulators in hepatic lipid and glucose metabolism. J Molcular Cellular Biolology 2016 (invited review,accepted) 6.Wang C, Chen Z, Li S, Zhang Y, Jia S, Li J, Chi Y, Miao Y, Guan Y, Yang J*. Hepatic overexpression of ATP synthase β subunit activates PI3K/Akt pathway to ameliorate hyperglycemia of diabetic mice. Diabetes. 2014, 63:947-59 . 7.Wang C, Chi Y, Li J, Miao Y, Li S, Su W, Jia S, Chen Z, Du S, Zhang X, Zhou Y, Wu W, Zhu M, Wang Z, Yang H, Xu G, Wang S, Yang J*, and Guan Y*.FAM3A activates p110α/Akt signaling to ameliorate hepatic gluconeogenesis and lipogenesis. Hepatology. 2014, 59:1779-1790. 8.Jia S, Chen Z, Li J, Chi Y, Wang J, Li S, Luo Y, Geng B, Wang C, Cui Q, Guan Y and Yang J*. FAM3A promotes vascular smooth muscle cell proliferation and migration and exacerbates neointima formation in rat artery after balloon injury J Mol Cell Cardiol . 2014, 74:173-182. 9.Ma W, Zhang L, Zeng P, Huang C, Li J, Geng B, Yang J, Kong W, Zhou X, Cui Q. An analysis of human microbe-disease associations. Brief Bioinform . 2016 Feb 15. pii: bbw005. [Epub ahead of print] 10.Liao F, Zheng Y, Cai J, Fan J, Wang J, Yang J, Cui Q, Xu G, Tang C, Geng B. Catestatin attenuates endoplasmic reticulum induced cell apoptosis by activation type 2 muscarinic acetylcholine receptor in cardiac ischemia/reperfusion. Sci Rep . 2015 Nov 16;5:16590. doi: 10.1038/srep16590. 11.Liu Y, Yang J and Chen L. Structure and function of SLC4 family HCO3– transporters. Front Physiol . 2015 Dec 1;6:355. eCollection 2015. 12.Wang DK, Liu Y, Myers EJ, Guo YM, Xie ZD, Jiang DZ, Li JM, Yang J, Liu M, Parker MD, Chen LM. Effects of Nt-truncation and coexpressing isolated Nt domain on membrane trafficking of electroneutral Na+/HCO3- cotransporters. Sci Rep . 2015 Jul 20;5:12241. doi: 10.1038/srep12241.. 13.Li J, Ma W, Zeng P, Wang J, Geng B, Yang J, Cui Q. LncTar: a tool for predicting the RNA targets of lncRNAs. Brief Bioinform .2015, Sep;16(5):806-12. 14.Wang C, Geng B, Cui Q, Guan Y and Yang J*. Intracellular and extracellular adenosine triphosphate in regulation of insulin secretion in pancreatic beta cells J Diabetes . 2014, 6:113-119. 15.Wei B, Cai L, Sun D, Wang Y, Wang C, Chai X, Xie F, Su M, Ding F, Liu J, Yang J, Guan Y and Liu X. Microsomal Prostaglandin E Synthase-1 Deficiency Exacerbates Idiopathic Pulmonary Fibrosis Induced by Bleomycin in Mice. Molecules. 2014, 19:4967-85. 16.Li Y, Qiu C, Tu J, Geng B, Yang J, Jiang T and Cui Q. HMDD v2.0: a database for experimentally supported human microRNA and disease associations. Nucleic Acids Research. 2014, 42:D1070-4 17.Zhou Y, Jia S, Wang C, Chen Z, Chi Y, Li J, Xu G, Guan Y and Yang J*. FAM3A is a target gene of peroxisome proliferator activated receptor-gamma. Biochim Biophys Acta . 2013,1830: 4160-4170. 18.Chen Z, Jia S, Li D, Tu J, Geng B, Guan Y, Cui Q and Yang J*. Silencing of long noncoding RNA AK139328 attenuates ischemia-reperfusion injury in mouse livers. 2013 PloS One . November 2013, 8(11): e80817. 19.Yang J and Guan Y. Family with sequence similarity 3 and non-alcoholic fatty liver diseases. J Gastroen Hepatol 2013, S1:105-11. 20.Yang J,Kang J and Guan Y. The mechanisms linking adiposopathy to type 2 diabetes. Front Med. 2013,7(4):433-44. 21.Li Y, Chen G, Wang D, Li Z, Zhou S, Wen J, Geng B, Yang J and Cui Q. Genome-wide analysis of human microRNA stability. BioMed Res Int 2013;2013:368975. doi: 10.1155/2013/368975. Epub 2013 Sep 28. 22.Li D, Chen G, Yang J, Fan X, Gong Y, Xu G, Cui Q, Geng B. Transcriptome analysis reveals distinct patterns of long noncoding RNAs in heart and plasma of mice with heart failure. PloS One . 2013 Oct 29;8(10):e77938. 23.Geng B, Cai B, Liao F, Zheng Y, Zeng Q, Fan X, Gong Y, Yang J, Cui QH, Tang C, Xu GH. Increase or Decrease Hydrogen Sulfide exert Opposite Lipolysis, but Reduce Global Insulin Resistance in High Fatty Diet Induced Obese Mice. PloS One . 2013 Sep 13;8(9):e73892 24.Wu J, Wang C, Li S, Li S, Wang W, Li J, Chi Y, Yang H, Kong X, Zhou Y, Dong C, Wang F, Xu G, Yang J, Gustafsson J?, Guan Y. Thyroid hormone-responsive spot 14 protein promotes hepatic lipogenesis, and its expression is regulated by LXRα through an SREBP1c-dependent mechanism. Hepatology . 2013;58:617-28 . 25.Wang C, Burkhardt BR, Guan Y and Yang J*. Role of pancreatic derived factor in type 2 diabetes: evidence from pancreatic β cells and liver. Nutr Rev .2012, 70:100-6. 26.Yang J, Zhou Y, Guan Y. PPARγ as a therapeutic target in diabetic nephropathy and other renal diseases. Curr Opin Nephrol Hypertens . 2012, 21:97-105. 27.Zhou Y, Wang C, Li J, Chi Y, Jia S, Guan Y and Yang J*. Expression of PANDER in the pancreas of diabetic mice. Basic & Clinical Med icine . 2012, 32 (7): 756-760. (in Chinese) 28.Li J, Chi Y, Wang C, Wu J, Yang H, Zhang D, Zhu Y, Wang N, Yang J*, Guan Y*.Pancreatic-derived factor promotes lipogenesis in the mouse liver: role of the Forkhead box 1 signaling pathway. Hepatology . 2011, 53:1906-16. 29.Zhu S, Xue R, Zhao P, Fan FL, Kong X, Zheng S, Han Q, Zhu Y, Wang N, Yang J*, Guan Y*. Targeted disruption of the prostaglandin E2 E-prostanoid 2 receptor exacerbates vascular neointimal formation in mice. Arterioscler Thromb Vasc Biol . 2011, 31:1739-47 30.Han Q, Zhang X, Xue R, Yang H, Zhou Y, Kong X, Zhao P, Li J, Yang J, Zhu Y, Guan Y.AMP-activated protein kinase potentiates hypertonicity-induced apoptosis by blocking the NF-kappaB/COX-2 survival pathway in renal medullary interstitial cells. J Am Soc Nephrol . 2011, 22:1897-911 31.Zhou Y, Kong X, Zhao P, Yang H, Chen L, Miao J, Zhang X,Yang J, Ding J, Guan Y. Peroxisome proliferator-activated receptor-α is renoprotective in doxorubicin-induced glomerular injury. Kidney Int . 2011, 79:1302-11. 32.Zhang D, Yang H, Kong X, Wang K,Mao X, Yan X, Wang Y, Liu S, Zhang X, Li J, Chen L, Wu J, Wei M, Yang J and Guan Y. Proteomics analysis reveals diabetic kidney as a ketogenic organ in type 2 diabetes. Am J Physiol : Endo and Meta .2011, 300:287-95. 33.Wang C, Guan Y and Yang J*. Cytokines in the progression of pancreatic beta cell dysfunction. Int J Endocrinol . 2010;2010:515136. Epub 2010 Nov 14. 34.Robert-Cooperman CE, Carnegie JR, Wilson CG, Yang J, Cook JR, Wu J, Young RA, Wolf BA, Burkhardt BR. Targeted disruption of pancreatic derived factor (PANDER, FAM3B) impairs pancreatic beta cell function. Diabetes . 2010, 59:2209-18. 35.Yang J*, Chi Y, Burkhardt BR, Guan Y and Wolf BA. Leucine metabolism in regulation of insulin secretion from panceatic beta cells. Nutr Rev . 2010, 68: 270-279. 36.Yang J*, Wang C, Li J, Burkhardt BR, Robert-Cooperman CE, Wilson C, Gao Z, Wolf BA. PANDER binds to the liver cell membrane and inhibits insulin signaling in HepG2 cells. FEBS Lett . 2009, 583: 3009-3015. 37.Li J, Zhu S, Zhang Y, Chi YJ, Tang JG, Yang JC*. Human leptin dimerization during refolding is predominantly mediated by Cys146-Cys146 intermolecular disulfide bond. Chin J of Biochem and Mol Biology 2009, 25: 333-338. 38.Li J, Zhang DJ, Zhang Y, Huang W, Tang JG and Yang JC*. Tyr61 Aromatic Side Chain is Critical for Spatial Structure Formation of Leptin. Chin J of Biochem and Mol Biology . 2009, 25: 235-241. 39.Zhang H, Wang WP, Guo T, Yang JC, Chen P, Ma KT, Guan YF, Zhou CY. The LIM-Homeodomain Protein ISL1 Activates Insulin Gene Promoter Directly through Synergy with BETA2. J Mol Biol . 2009,392:566-577. 40.Chen L, Yang G, Zhang X, Wu J, Gu Q, Wei M, Yang J, Zhu Y, Wang N, Guan Y. Induction of MIF expression by oxidized LDL via activation of NF-kB in vascular smooth muscle cells. Atherosclerosis 2009, 207:428-33. 41.Yang J, Zhang D,Li J,Zhang X, Fan F and Guan Y. Role of PPAR-γ in renoprotection in Type 2 diabetes: molecular mechanisms and therapeutic potential. Clin Sci . 2009, 116: 17-26. 42.Yang J,Chen L, Zhang X, Zhou Y, Zhang D, Huo M, and Guan Y. PPARs and female reproduction: Evidence from genetically manipulated mice. PPAR Res .2008 , 2008:723243. 43.Yang J, Wong RK, Park MJ, Wu J, Cook JR, York DA, Deng S, Markmann J, Naji A, Wolf BA and Gao Z. Leucine regulation of glucokinase and ATP synthase sensitizes glucose-induced insulin secretion in pancreaticβcells. Diabetes . 2006, 55: 193-201. 44.Yang J, Robert CE, Burkhardt BR, Young RA, Wu J, Gao Z and Wolf BA. Mechanisms of glucose-induced secretion of pancreatic derived factor (PANDER or FAM3B) in pancreatic beta cells. Diabetes . 2005, 54:3217-3228. 45.Yang J, Gao Z, Robert CE, Burkhardt BR, Gaweska H, Wagner A, Wu J, Greene SR, Young RA and Wolf BA. Structure-Function Studies of PANDER, an Islet Specific Cytokine Inducing Cell Death of Insulin Secreting beta Cells. Biochemistry . 2005, 44:11342-11352. 46.Yang J, Wong RK, Wang X, Moibi J, Hessner MJ, Greene S, Wu J, Sukumvanich S, Wolf BA and Gao Z. Leucine culture reveals that ATP synthase functions as a fuel sensor in pancreatic beta cells. J. Biol. Chem . 2004, 279:53915-53923. 47.Yang J, Liu J, Yang X and Tang J. Gene therapy for diabetic rats by electroporational transfer of naked plasmid with human pre-pro-insulin gene into skeletal muscle. Biotechnol Lett . 2002, 24:851-855. 48.Narayan SB, Rakheja D, Pastor JV, Rosenblatt K, Yang J, Wolf BA and BennettMJ. Over-expression of CLN3P, the Batten disease protein inhibits PANDER-induced apoptosis in neuroblastoma cells:CLN3P is a novel anti-apoptotic protein. Mol Genet and Metab . 2006, 88:178-83. 49.Burkhardt BR, Greene SR, White P, Wong RK, Brestelli JE, Yang J, Robert CE, Brusko T, Wasserfall CH, Wu J, Atkinson MA, Gao Z, Kaestner KH and Wolf BA. PANDER-induced cell-death genetic networks in islets reveal central role for caspase-3 and cyclin-dependent kinase inhibitor 1A (p21). Gene . 2006, 369: 134-41. 50.Burkhardt BR, Yang MC, Robert CE, Greene SR, McFAdden KK, Yang J, Wu J, Gao Z, Wolf BA. Tissue-specific and glucose-responsive expression of the pancreatic derived factor (PANDER) promoter. Biochim Biophys Acta . 2005, 1730:215-25. 51.Cao X, Yang J, Burkhardt B, Gao Z, Wong RK, Greene S, Wu J, and Wolf BA. Effects of over-expression of Pancreatic-Derived Factor (FAM3B) in isolated mouse islets and beta-TC3 cells. Am J Physiol : Endo and Meta. 2005, 289:543-550. 52.Wang XD, Tang JG, Xie XL, Yang JC, Li S, Ji JG and Gu J. A comprehensive study of optimal conditions for naked plasmid DNA transfer into skeletal muscle by electroporation. J Gene Med . 2005, 7:1235-1245. 53.Wang XD, Liu J, Yang JC, Chen WQ and Tang JG. Mice body weight gain is prevented after naked human leptin cDNA transfer into skeletal muscle by electroporation. J Gene Med . 2003, 5:966-76. (IF="4.6) 54.Chen Zhenzhen and Yang Jichun*. ATP-P2 receptor signaling pathway in regulation of glucose and lipid metabolism in the liver. 2016 (submitted) 55.Chi Y, Li Jing, Chen Z, Ding L, Yang W, Luo Y and Yang J*. FAM3A promotes adipogenesis of 3T3-L1 preadipocytes via activation of ATP-P2-Akt signaling pathway. 2015 (submitted for publication) 56.Chen Z, Luo Y, Yang W, Ding L, Geng B, Cui Q and Yang J*. FAM3A is essential for PPARg’s protective effects against liver injury during ischemia/reperfusion. 2016 (submitted for publication) 57.Ding L, Chen Z, Yang W, Wang J, Chen L, Chang Y, Geng B, Cui C and Yang J*. FAM3C (ILEI) attenuates hyperglycemia and fatty liver of obese diabetic mice via calmodulin-dependent activation of Akt pathway. 2016 (submitted for publication). 58.Yang W, Chen Z, Ding L, Wang J, Chen L, Chang Y, Geng B, Cui C and Yang J*. miR-423-5p targets FAM3A-ATP-Akt pathway to regulated glucose and lipid metabolism. 2016 (submitted for publication) 59.李晶 张园 赵明明 杨吉春*.胰岛特异细胞因子PANDER在糖尿病病理生理过程中的作用. 生理科学进展 2008, 39(4):339-342. 60.李晶 张园 管又飞 杨吉春*.ATP合成下降在β细胞功能障碍中的作用 生理科学进展 2009, 40(1): 47-50. 61.王春炅 张园 管又飞 杨吉春*. 瘦素在机体糖脂代谢中的调控作用. 中国生物化学与分子生物学报 . 2009, 25(10): 896-902. 62.迟毓婧 李晶 管又飞 杨吉春*. PI3K-Akt信号传导通路对糖代谢的调控作用. 中国生物化学与分子生物学报 2010, 26(10):879-885. 63.迟毓婧 李晶 管又飞 杨吉春*. 1型糖尿病基因疗法的回顾与展望. 生理科学进展 2010, 41(1):55-58 64.周艳兰 迟毓婧 管又飞 杨吉春*. 脂肪细胞因子与脂肪细胞发育分化. 中国生物化学与分子生物学报 2011, 27(3):212-217. 65.周艳兰 王春炅 管又飞 杨吉春*. FAM3基因家族的研究进展. 生理科学进展 2013,44(2):19-23. 66.贾石 王春炅 管又飞 杨吉春*. 脂肪因子与动脉粥样硬化. 2013 生理科学进展 (submitted) 67.王春炅 贾石 陈真真 杨吉春*. PANDER与糖脂代谢. 生理科学进展 2013, 44, 425-428. 68.杨卫利 王君佩 崔庆华 杨吉春. 非编码RNA与肝脏糖脂代谢. 生理科学进展 2016 (in press) 69.王婉奕 朱森 杨吉春 管又飞. Resistin与肥胖和2型糖尿病 生理科学进展 2009, 40(2): 157-160. 70.霍明 臧会玲 张冬娟 王冰 吴静 张晓燕 陈丽红 李晶 杨吉春 管又飞. ChREBP活性增加在2型糖尿病模型db/db小鼠肝脏脂质过度沉积中的作用. 北京大学学报(医学版) 2009, 41(3):307-312. 71朱森 杨吉春 管又飞. 前列腺素E2受体亚型EP2和EP4的最新研究进展. 临床医学工程 . 2009,16(7): 109-111. 72.杨航 杨吉春 管又飞. AMPK在糖脂代谢中的作用 生理科学进展 2009, 40(3):249-252 73.赵攀 杨吉春 管又飞. PPARβ/δ在炎症性疾病中的作用. 中国药理学通报 . 2009, 25(9):1124-1127 74.霍明 杨吉春 管又飞. ChREBP在肝细胞糖脂代谢中的作用. 生理科学进展 2009, 40(4): 337-340. 75.张冬娟 杨吉春 管又飞. 蛋白质组学技术在糖尿病肾病研究中的应用. 生理科学进展 . 2010, 41(2):129-132. 76.苗一非 康继宏 杨吉春 管又飞. 前列腺素E受体与血压调节. 中国药理学通报 2010, 26(4):424-427 77.杨航 杨吉春 管又飞. 高渗应激对肾髓细胞的影响. 生理科学进展 . 2010,41(4):287-290. 78.薛瑞 杨吉春 管又飞. 前列腺素E2(PGE2)对免疫系统的调控作用. 生理科学进展 2011, 42(3):165-168. 79..藏会玲 王春炅 杨吉春 管又飞. PPARγ在糖尿病肾病中的保护作用. 生理科学进展 2010, 41(6):435-438. 80.孔晓牧 杨吉春 管又飞. 主要尿蛋白(MUPs)的研究新进展. 中国生物化学与分子生物学报 2011, 27(3):197-204. 翻译著作 1. 格林童话全集(德) 格林兄弟著. 杨吉春刘丽亚 译. 陕西师范大学出版社,2007年 2. Train Your Brain For A Fast-Track Career. Jacqueline Renaud-杰出大脑的7种能力. 杨吉春房利娟译。中国大百科出版社,2004年。<ref>[https://sbms.bjmu.edu.cn/xygk/xyjj/index.htm 北京大学基础医学院]</ref> ==参考资料== {{reflist}} [[Category:教授]]
此頁面使用了以下模板:
Template:Main other
(
檢視原始碼
)
Template:Reflist
(
檢視原始碼
)
模块:Check for unknown parameters
(
檢視原始碼
)
返回「
杨吉春
」頁面